Kadant Inc (KAI) Drops 5.57% on January 04

Equities Staff |

Kadant Inc (KAI) was one of the Russell 2000's biggest losers for Monday January 04 as the stock slid 5.57% to $38.35, a loss of $-2.26 per share. Starting at an opening price of $40.08 a share, the stock traded between $37.91 and $40.08 over the course of the trading day. Volume was 18,729 shares over 245 trades, against an average daily volume of 57,708 shares and a total float of 10.78 million.

The losses send Kadant Inc down to a market cap of $413.41 million. In the last year, Kadant Inc has traded between $56.29 and $37.72, and its 50-day SMA is currently $41.42 and 200-day SMA is $45.04.

The stock has a P/E Ratio of 13.6.

Kadant Inc develops, manufactures, and markets equipment and products for the papermaking, paper recycling and other process industries. It also designs and manufactures stranders and related equipment used in the production of oriented strand board.

Kadant Inc is based out of Westford, MA and has some 1,800 employees. Its CEO is Jonathan W. Painter.

For a complete fundamental analysis analysis of Kadant Inc, check out Equities.com’s Stock Valuation Analysis report for KAI. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets


Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…


Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.